 |
|
|
|
 |
|
|
| Article 1 to 6 out of 6 concerning PharmaCell BV
|
-
Maastricht University and PharmaCell publish results on possible improved immune reconstitution for acute leukemia patients
(21 Jan 2010)
In a collaborative publication in the journal Blood, PharmaCell BV, the Maastricht University, Institute for Research in Biomedicine in Switzerland and the Research Center for Allergy and Immunology in Japan present data on a novel approach to ...
-
PharmaCell B.V. appoints new CEO
(03 Nov 2009)
PharmaCell B.V. has appointed Mr. Alexander Vos as Chief Executive Officer, effective November 1st 2009. Mr. Vos has 20 years of leadership experience in the pharma and biotech industry. He joins from PAION AG, where he was a Member of the ...
-
Drug development program started based on CAP Human Cell Line
(05 Mar 2009)
New platform may provide solutions for many RA-patients around the world
Alloksys Life Sciences BV, CEVEC Pharmaceuticals GmbH and PharmaCell BV announced the start of Theraptech, a 2.4 million Euro therapeutic protein development program subsidized under the European Trans Bio Program. The major objective of the ...
-
Public-private partnership in biomedical materials will give a boost to medical innovation and the Dutch knowledge-based economy
(18 May 2006)
Universities and companies joining forces to give the Netherlands a leading position in Biomedical Materials
A consortium of leading Dutch industrial companies, small and medium-sized companies, knowledge institutes and public organizations recently convened a meeting in the Dutch city of Den Bosch to confirm their partnership in the BioMedical Materials ...
-
CyGenics Expands Into Europe
(12 Apr 2006)
Plans to acquire stake in PharmaCell
CyGenics Ltd. announced its plans to establish a sound base in the European market to take advantage of exciting business opportunities in those markets. As a first step, CyGenics plans to acquire a significant stake in Dutch-based PharmaCell BV. ...
-
CyGenics in International Cancer Therapy Collaboration
(06 Feb 2006)
International effort to develop new cancer treatment
CyGenics Ltd. announced that it will be part of a new international collaborative effort to develop new treatments for cancer. This will be done via the novel approach of developing and mobilising immune cells outside the human body. Called PACRIMA, ...
Additional information
PharmaCell BV
Maastricht, Netherlands
Company
|
|
|
|
|
|
Top
